LBPS
4D pharma

530
Mkt Cap
$37.19M
Volume
3,914.00
52W High
$10.84
52W Low
$1.50
PE Ratio
-0.43
LBPS Fundamentals
Price
$1.65
Prev Close
$1.61
Open
$1.61
50D MA
$2.90
Beta
0.54
Avg. Volume
14,806.86
P/B
1.18
Loading...
Loading...
4D is a world leader in the development of live biotherapeutics, a novel and emerging class of drugs, defined by the FDA as biological products that contain a live organism, such as a bacteria, that is applicable to the prevention, treatment or cure of a disease. 4D has developed a proprietary platform, MicroRx, that rationally identifies novel bacteria that have a precise and evolved therapeutic effect. All of 4D's live biotherapeutic products are orally delivered single strains of bacteria that are naturally found in the healthy human gut. 4D currently has a pipeline of 15 therapeutic programmes covering autoimmune diseases, CNS disorders and cancer; with two programmes in patient trials, and the expectation to initiate another three programmes over the coming twelve months.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of 4d Pharma Plc - ADR?
What is the 52-week high for 4d Pharma Plc - ADR?
What is the 52-week low for 4d Pharma Plc - ADR?
What is 4d Pharma Plc - ADR stock price today?
What was 4d Pharma Plc - ADR stock price yesterday?
What is the PE ratio of 4d Pharma Plc - ADR?
What is the Price-to-Book ratio of 4d Pharma Plc - ADR?
What is the 50-day moving average of 4d Pharma Plc - ADR?

Latest LBPS News

View
No LBPS news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.